Ozempic, Wegovy could help type 1 diabetics: Study

Ozempic and Wegovy, made by Novo Nordisk (NVO), traditionally have been used to treat patients with type 2 diabetes, though they have gained notoriety as weight loss drugs. Research published by the New England Journal of Medicine shows that Semaglutide, the ingredient behind Ozempic and Wegovy, may also help those with type 1 diabetes. Yahoo Finance's Anjalee Khemlani reports on what these new findings mean for those living with diabetes, as well as what it means for Novo Nordisk, who may not be able to keep up with the demand for these popular drugs. CEO Lars Jorgensen told Reuters that "I think for the foreseeable future, we'll have a situation where demand will be larger than what we can supply."